Advancing Evidence-Based and Personalized Treatment of Rheumatoid Arthritis: Focus on Difficult-to-Treat, Multi-Morbid, and Aging Patient Populations

Registration link: Click here 

The treatment and management of RA has advanced significantly, enabling many patients to achieve low disease activity or remission. However, key populations face unique challenges requiring specialized care and considerations, including:

• Difficult-to-treat RA – overcoming therapeutic resistance and managing progressive disease
• Multimorbid RA – addressing cardiovascular risks, interstitial lung disease, and polypharmacy
• Aging RA – tailoring treatment to late-onset RA, frailty, and systemic complications

Whether you are new in rheumatology, or a seasoned clinician, register for our upcoming Virtual Summit in RA to stay up to date with evolving evidence and gain skills needed to optimize treatment for these high-risk patients!

What you’ll get:

• Practical strategies to personalize treatment & improve long-term outcomes
• Updates on the latest evidence & guidelines on disease & comorbidity management
• Actionable insights from top rheumatology and cardiology experts
• 1.5 CME/MOC credits—FREE!

Register now to save your spot!

How To Participate 

This is a virtual event, so please register following these 3 easy steps:

1. Go to our registration page and register for the Summit.
2. Save your registration email with your link and login information.
3. Log in to the virtual meeting app during the Summit to participate!

The companion virtual meeting app allows you to watch the Summit livestream, review the program agenda and faculty information, send questions, participate in polling questions, complete pre- and post-activity surveys, and find information to claim CME/MOC credits!

No download necessary, the web app runs on your device’s browser!

Location: Virtual Only*

Summit Details

Date: November 15, 2025

Time: 12:00 PM – 15:20 EST

Chairs:

• Grace C. Wright, MD, PhD, FACR
  AWIR President and Founder
• Priya Reddy, MD, FACR
  AWIR Secretary and Treasurer

Speakers

• To be confirmed
  

Program

12:00-12:10 - Welcome Remarks

12:10-12:40  - Accredited Session (1.5 CME/MOC)

14:10-14:25  - Break

14:25-14:40  - Roundtable

14:40-15:10  - Product Theater

15:10-15:20  - Closing Remarks

CME Session Information

Learning Objectives:

• Discuss the impact of multimorbid, treatment-resistant, and elderly-onset disease on RA treatment and outcomes.
• Differentiate established, new, and emerging targeted therapies for RA based on mechanisms of action, indications, efficacy, and safety data.
• Apply key evidence, updated guidelines, and patient factors to individualize treatment decisions for RA patients with difficult-to-treat, multimorbidity, or aging disease.
  
• Implement interprofessional strategies to enhance collaboration between rheumatology and other specialties in managing complex RA patients.

Agenda: 

• Updates and Overview of RA Treatment Landscape
• Difficult-to-Treat RA: Treatment Initiation and Switching
• RA and ILD: Management and Impact on Patient Care
• Healthy Aging and RA: Personalized Treatment Approaches
• Interdisciplinary Strategies for Collaborative Care